Surging global incidence of diabetic autonomic neuropathy, expanding clinical adoption of non-invasive nasal spray delivery systems, and continuous biopharmaceutical refinements in selective serotonin $5\text{-HT}_4$ receptor agonists are driving rapid growth across the global Gastroparesis Drugs Market. Gastroparesis pharmacotherapies—comprising dopamine $\text{D}_2$ receptor antagonists...
